301009.SHE Hangzhou Coco Healthcare Products Co.Ltd.
- Market cap
- CNY 2.16B
- P/E
- -
- P/B
- 1.66x
- ROE
- -1.2%
- Dividend yield
- 0.94%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 301009.SHE undervalued?
Graham numberThe Graham number of Hangzhou Coco Healthcare Products Co.Ltd. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Hangzhou Coco Healthcare Products Co.Ltd. fundamental analysis
No fundamental analysis for Hangzhou Coco Healthcare Products Co.Ltd. yet.
Hangzhou Coco Healthcare Products Co.Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Hangzhou Coco Healthcare Products Co.Ltd.
Hangzhou Coco Healthcare Products Co.,Ltd. engages in the research, development, production, and sale of baby care, adult incontinence, and feminine and pet hygiene products in China and internationally. It offers adult incontinence products, including adult diapers, adult pull-up pants, nursing pads, maternity towels, menstrual pants, absorbent towels, and other products under the Reliable, Absorbent Treasure, and Anhushi brands. The company was formerly known as Hangzhou Q…
Full company profileHangzhou Coco Healthcare Products Co.Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Hangzhou Coco Healthcare Products Co.Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 787M | 906M | 1.17B | 1.64B | 1.19B | 1.19B | 1.08B | 1.08B | 1.15B | 1.17B |
| Gross Profit | 223M | 230M | 316M | 453M | 213M | 144M | 181M | 212M | 276M | 273M |
| Operating Income | 50.1M | 66.2M | 108M | 255M | 45.3M | -55.5M | 20.2M | 31.0M | 35.6M | 14.4M |
| EBITDA | 85.0M | 101M | 142M | 298M | 93.1M | 4.50M | 74.6M | 88.1M | 104M | -17.4M |
| Net Income | 41.9M | 59.7M | 87.5M | 214M | 39.7M | -43.1M | 20.2M | 31.2M | 36.1M | -15.8M |
| EPS | 0.21 | 0.30 | 0.44 | 1.05 | 0.17 | -0.16 | 0.07 | 0.12 | 0.13 | -0.06 |
| Balance Sheet | ||||||||||
| Total Assets | 957M | 996M | 1.07B | 1.49B | 2.09B | 1.95B | 1.99B | 2.09B | 2.18B | 2.19B |
| Total Liabilities | 485M | 461M | 614M | 812M | 579M | 517M | 542M | 678M | 756M | 810M |
| Shareholders' Equity | 431M | 483M | 399M | 613M | 1.41B | 1.35B | 1.37B | 1.33B | 1.34B | 1.30B |
| Cash & Short-term Investments | 244M | 231M | 200M | 439M | 884M | 689M | 863M | 864M | 811M | 671M |
| Total Debt | 50.0M | 11.0M | 40.9M | 99.2M | 6.61M | 4.64M | 18.1M | 108M | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | 110M | 114M | 223M | 396M | 50.5M | -37.2M | 228M | 52.4M | 127M | - |
| Capital Expenditure | 77.4M | 89.8M | 126M | 221M | 240M | 116M | 66.0M | 75.4M | 39.9M | 90.9M |
| Free Cash Flow | 32.3M | 24.5M | 97.5M | 175M | -190M | -154M | 162M | -22.9M | 86.9M | -38.9M |
| Ratios | ||||||||||
| ROE | 9.7% | 12.4% | 21.9% | 34.9% | 2.8% | -3.2% | 1.5% | 2.3% | 2.7% | -1.2% |
| ROA | 4.4% | 6.0% | 8.2% | 14.3% | 1.9% | -2.2% | 1.0% | 1.5% | 1.7% | -0.7% |
| Net Profit Margin | 5.3% | 6.6% | 7.5% | 13.1% | 3.4% | -3.6% | 1.9% | 2.9% | 3.1% | -1.4% |
| Debt to Equity | 0.12x | 0.02x | 0.10x | 0.16x | 0.00x | 0.00x | 0.01x | 0.08x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Hangzhou Coco Healthcare Products Co.Ltd. dividends
- Dividend yield
- 0.94%
- Forward dividend
- 0.12 CNY
- Payout ratio
- 56.0%
- Ex-dividend date
- Jun 25, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 20.2M | 0.07 | 56.0% |
| 2024 | CNY 20.1M | 0.08 | 64.6% |
| 2023 | - | - | - |
| 2022 | CNY 19.0M | 0.07 | - |
| 2021 | CNY 883K | 0.00 | 2.2% |
| 2020 | CNY 23.6M | 0.12 | 11.0% |
| 2019 | CNY 180M | 0.90 | 206.4% |
| 2018 | 1.53M | 0.01 | 2.6% |
| 2017 | 46.6M | 0.23 | 111.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Hangzhou Coco Healthcare Products Co.Ltd.
- Insiders 64.68%
- Institutions 1.57%
- Public & others 33.75%
- Shares outstanding 272M
- Free float 88.2M
Hangzhou Coco Healthcare Products Co.Ltd. company profile
- Company name
- Hangzhou Coco Healthcare Products Co.Ltd.
- Ticker
- 301009.SHE
- ISIN
- CNE100004LL1
- Exchange
- Shenzhen Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 756
- Fiscal year end
- December
- Address
- Chengxi Industrial Park, Hangzhou, China, 311300
- Phone
- 86 57 1637 02088
- Website
- cocohealthcare.com
About Hangzhou Coco Healthcare Products Co.Ltd.
Hangzhou Coco Healthcare Products Co.,Ltd. engages in the research, development, production, and sale of baby care, adult incontinence, and feminine and pet hygiene products in China and internationally. It offers adult incontinence products, including adult diapers, adult pull-up pants, nursing pads, maternity towels, menstrual pants, absorbent towels, and other products under the Reliable, Absorbent Treasure, and Anhushi brands. The company was formerly known as Hangzhou Qiaozi Paper Industry Co.,Ltd. and changed its name to Hangzhou Coco Healthcare Products Co.,Ltd. in December 2011. Hangzhou Coco Healthcare Products Co.,Ltd. was incorporated in 2001 and is headquartered in Hangzhou, China.
Hangzhou Coco Healthcare Products Co.Ltd. management
5- Mr. Liwei JinCEO & Chairman of the Board · born 1970
- Ms. Chaonan LiDeputy GM & Financial Director · born 1982
- Ms. Zhongying ZhouDeputy GM & Director · born 1968
- Mr. Xiang Ting WangDeputy GM & Board Secretary · born 1975
- Jianjian DingAccounting Supervisor